Kidney cancer Doctors in test — Page 2

Dr. Amit Tirosh is the Head of the Neuroendocrine Tumors (NET) Service at Sheba Medical Center. He is an international authority on von Hippel–Lindau (VHL) disease and hereditary tumor syndromes. Dr. Tirosh contributed to global clinical guidelines for VHL management. He also leads the Endocrine Oncology Bioinformatics Lab at Sheba.

• Contributor to the international expert panel on VHL management guidelines.
• Authored over 40 peer-reviewed papers in journals like JAMA and Gastroentrology.
• Maintains research affiliations with the NIH and the Weizmann Institute.
• Performs specialized NET treatments, including Lutetium-177 therapy and PRRT.

Dr. Yuri Goldes is the Deputy Director of General Surgery at Sheba Medical Center. He pioneered some of Israel’s first robotic resections for stomach and pancreatic cancers. Forbes Israel named him among the nation’s best gastrointestinal surgeons. In 2019, he received the Best Doctor of the Year award from the Israeli Ministry of Health.

• Specializes in robotic and laparoscopic surgery for pancreatic, gastric, and esophageal cancers.
• Performs minimally invasive Whipple procedures, one of the most complex abdominal operations.
• Treats benign conditions including diaphragmatic hernia, achalasia, GERD, and gallbladder disease.
• Works at Sheba Medical Center, ranked among the Top 10 hospitals worldwide by Newsweek.

Head of Radiation Oncology at German Oncology Center with over 13 years of experience of focused experience. Specializes in advanced radiation treatments for kidney cancer.

• Doctoral degree from Johann Wolfgang Goethe University
• Specialist in interventional Radiation Oncology procedures
• Master's in Healthcare Business Studies
• Senior physician experience at Klinikum Offenbach

Dr. Sinan Karaaslan is a medical oncologist at Anadolu Medical Center in Istanbul. He specializes in treating breast, colorectal, and urogenital system cancers. Dr. Karaaslan brings clinical expertise from major institutions, including Medical Park and Gülhane Military Medical Academy. He works at a hospital affiliated with the Johns Hopkins Hospital.

• Holds personal certification from the European Society for Medical Oncology.
• Treats complex conditions, including stage 4 colon and lung cancers.
• Member of the Turkish Medical Oncology and Turkish Lung Cancer societies.
• Performs systemic therapies such as immunotherapy, targeted therapy, and chemotherapy.

Dr. Serkan Keskin achieved 1st place nationally in his Medical Oncology board exam. He works with advanced treatments like immunotherapy at Memorial Şişli Hospital.

• Over 25 years of experience of experience treating complex cancers
• Uses advanced techniques including targeted therapy and chemotherapy
• Holds membership in leading global societies like ASCO and ESMO
• Recognized with the Best Poster Award at a National Cancer Congress
• Completed his oncology subspecialty training at Istanbul University Institute of Oncology

Professor Yesim Yildirim specializes in cancer immunotherapy and targeted therapies, with over 80 publications and international recognition.

• Member of European Society of Medical Oncology (ESMO)
• Trained in Melanoma and Kidney Cancer Clinic at Mount Vernon Cancer Center
• Published co-author in 'Handbook of Advanced Cancer Care Treatment'
• Professor at Haliç University, Istanbul

Specialist Dr. Rahib Hasanov brings international oncology expertise from training at Houston Methodist Hospital and Marmara University.

• Completed Medical Oncology fellowship with focus on modern treatments
• Incorporates immunotherapies and targeted therapies for kidney cancer
• Treats patients from Europe, Middle East, and Central Asia
• Specializes in personalized oncology approaches

Dr. Seref Komurcu is a medical oncologist at Anadolu Medical Center in Istanbul. He specializes in treating breast, lung, colorectal, and solid cancers. Dr. Komurcu holds both ECFMG and ESMO certifications. He previously served as a professor at Gülhane Military Medical Academy.

• Published over 110 scientific papers on cancer management.
• Provides immunotherapy, targeted therapy, and chemotherapy treatments.
• Member of the American Society of Clinical Oncology.
• Works at a clinic affiliated with Johns Hopkins Medicine.

Assoc. Prof. Dr. Heves Sürmeli is a specialist in Internal Medicine and Medical Oncology. She received her medical degree (M.D.) from Eskişehir Osmangazi University in 2004. She completed her Internal Medicine residency at Kartal Dr. Lütfi Kırdar Training and Research Hospital, Istanbul (2005–2010). She then completed subspecialty training in Medical Oncology at the same hospital (2014–2017).

At the same center, she served as a Medical Oncology Specialist (2017–2023). She then worked as Administrative and Clinical Director (2023–2026). Her clinical interests include breast, lung, gynecologic, gastrointestinal, and urologic cancers.

She has published many articles in international peer‑reviewed journals. She has presented at national and international conferences. She is active in professional societies. She has received several awards.

Dr. Mehmet Dogu Canoglu is a radiation oncologist at Anadolu Medical Center in Istanbul. He specializes in precise tumor targeting using MR Linac and CyberKnife technologies. Dr. Canoglu trained at Kocaeli University. He previously served at Medipol Mega University Hospital. He treats various cancers, including complex brain, prostate, and lung tumors.

• Expert in Varian TrueBeam and Trilogy radiation delivery systems.
• Performs stereotaxic radiosurgery and targeted radiotherapy for sarcomas.
• Works at Anadolu Medical Center, a facility affiliated with Johns Hopkins Medicine.
• Treats patients at a clinic ranked among the world's top 10 for medical tourism.

Dr. Necdet Uskent is a medical oncologist and hematologist at Anadolu Medical Center in Istanbul. He was part of the pioneering team that performed Turkey's first bone marrow transplant. Dr. Uskent holds the European Medical Oncology Certificate and focuses on breast, lung, and gastrointestinal cancers. He works at a facility affiliated with Johns Hopkins Medicine.

• Founder of the Turkish Oncology Group (TOG).
• A founding member of the Turkish Society of Medical Oncology.
• Served as a visiting lecturer at Royal Free and University College Hospital in London.
• Treats complex hematological conditions including lymphomas and myeloma.

Professor of Medical Oncology since 2016 – Dr. Saglam leads the Gastrointestinal Oncology unit at Florence Nightingale Hospital.

• Over 29 years of experience of experience in medical oncology
• Specialized in gastrointestinal oncology since 2005
• Fellowship-trained at Istanbul University Oncology Institute
• Member of ESMO and ASCO professional societies

Specializes in lung, esophageal, and gastric cancers at Valued Med Hub Hospitals, bringing focused expertise to kidney cancer cases.

• Medical oncology specialist with training at Ankara Oncology Hospital
• Experience in multiple oncology clinics across Turkey
• Published researcher with work accessible on Google Scholar

Specializes in urogenital cancers with a strong research background in oncology – Dr. Sec is a member of the Turkish Medical Oncology Association.

• Over 14 years of experience of experience in medical oncology
• Published multiple studies on prognostic factors in cancer
• Works at Bahçelievler Medikalpark Hospital
• Represents specialist physicians in the Turkish Medical Oncology Association

Dr. Topcu specializes in a wide range of cancers, including kidney cancer, with training at top international centers like MD Anderson and Sunnybrook Odette.

• Medical oncology specialist with over 18 years of experience of experience
• Trained at MD Anderson Cancer Center and Sunnybrook Odette Cancer Center
• Works at Valued Med Hub Hospitals
• Specializes in multiple cancer types, including kidney cancer

Dr. Stepfansky is a senior oncologist at the renowned Sourasky Medical Center (Ichilov) where she directs the oncology hospitalization department.

• Has 26 years of experience of specialized experience in oncology and internal medicine
• Leads and participates in first, second, and third phase clinical trials for new cancer treatments
• Completed her specialized oncology internship at Ichilov Hospital
• Board-certified to practice medicine in Israel since 2000

Dr. Dror Levin specializes in pediatric oncology, with a focus on bone cancer (sarcoma) in children at Sourasky Medical Center.

• Director of children's hematology oncology department at Sourasky Medical Center
• Specialized in pediatric hematology and oncology at Schneider Children's Medical Center
• Member of the Israel association for pediatric hemato-oncology (ISPHO)
• Studied bone and soft tissue oncology at Rizzoli Orthopaedic Institute in Italy

Associate Professor Dr. Yusuf Acikgoz brings international oncology expertise from Ohio State University to Lokman Hekim University Ankara Hospital.

• Specializes in kidney cancer within medical oncology
• Assistant investigator in two major Phase III clinical trials for advanced treatments
• Completed specialized immunology-oncology training in Vienna
• Member of American Society of Clinical Oncology (ASCO)
• Certified in cutting-edge research practices from Ohio State University

Prof. Haim Matskin heads the Urology Department at Sourasky Medical Center, specializing in kidney cancer treatments.

• Expert in brachytherapy and cryotherapy for kidney cancer
• Recognized authority in onco-urology and urology
• Member of Medical Association of Israel and international urology associations

Prof. Köstler, an internationally recognized oncologist, brings over 22 years of experience of specialized experience to the Wiener Privatklinik.

• His expertise lies in breast cancer, gynecologic malignancies, and targeted cancer therapies.
• He is an Associate Professor at the Medical University of Vienna, focusing on translational cancer research.
• Prof. Köstler contributed to early clinical trials on personalized, targeted drug therapies.
• He leads in biomarker development and individualized systemic cancer treatment strategies.